Cargando…
Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs
One of the potential essential factors that restricts generic industry from applying the Biopharmaceutics Classification System (BCS) Class III biowaiver is adherence to the stringent formulation criteria for formulation qualitative (Q1) sameness and quantitative (Q2) similarity. The present study h...
Autores principales: | Ren, Ping, Chan, Theresa, Yang, Wen-Cheng, Frost, Mitchell, Wang, Yan, Luke, Markham, Kim, Myong-Jin, Lionberger, Robert, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534858/ https://www.ncbi.nlm.nih.gov/pubmed/37765334 http://dx.doi.org/10.3390/pharmaceutics15092366 |
Ejemplares similares
-
Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations
por: Belayneh, Anteneh, et al.
Publicado: (2020) -
Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets
por: Arafat, Mosab, et al.
Publicado: (2023) -
Effects of polyol excipient stability during storage and use on the quality of biopharmaceutical formulations
por: Sun, Min-Fei, et al.
Publicado: (2022) -
Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation
por: Dahan, Arik, et al.
Publicado: (2021) -
Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants
por: Zarmpi, Panagiota, et al.
Publicado: (2020)